[1]
L. A. Rodriguez Arrieta, P. A. Rueda Galvis, M. V. Rueda Galvis, S. A. Pantoja Meneses, J. M. Yépez Rodriguez, and F. J. Suarez Contreras, “When skin reactions interrupt bone therapy: severe cutaneous adverse reaction to romosozumab leading to treatment discontinuation”, EJCRIM, vol. 12, no. 9, Aug. 2025, doi: 10.12890/2025_05719.